Role of rosuvastatin and pitavastatin in alleviating diabetic cardiomyopathy in rats: Targeting of RISK, NF-κB/ NLRP3 inflammasome and TLR4/ NF-κB signaling cascades.
Diabetic cardiomyopathy (DCM) is a serious outcome of type II diabetes mellitus (T2DM) and a key contributor to high morbidity and death in diabetic individuals. The current research is intended to elucidate and compare the therapeutic benefits of rosuvastatin (RVS) and pitavastatin (PTS) in mitigat...
Saved in:
Main Authors: | Dalia O Saleh, Nesma M E Abo El Nasr, Marawan A Elbaset, Marwa E Shabana, Tuba Esatbeyoglu, Sherif M Afifi, Ingy M Hashad |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2025-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0325767 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
NfκBin: a machine learning based method for screening TNF-α induced NF-κB inhibitors
by: Shipra Jain, et al.
Published: (2025-07-01) -
Review of Small Molecule Anticancer NF-κB Inhibitors
by: Sh. R. Kzyrgalin, et al.
Published: (2023-07-01) -
ROLE OF NUCLEAR FACTOR NF-κB IN ALLOGRAFT REJEKTION
by: N. V. Kuncevich
Published: (2010-06-01) -
Spatiotemporal dynamics of NF-κB/Dorsal inhibitor IκBα/Cactus in Drosophila blastoderm embryos
by: Allison E. Schloop, et al.
Published: (2025-07-01) -
Separation-of-function mutants reveal the NF-κB-independent involvement of IκBα in the regulation of intestinal stemness
by: Daniel Álvarez-Villanueva, et al.
Published: (2025-07-01)